Article: P58 Extremely elevated C – reactive protein: a bad omen for haematological patients?

Related products

• 

  Article: INTRODUCTION

  €2.42 Add to cart
• 

  Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

  €2.42 Add to cart
• 

  Article: Highlights in respiratory oncology

  €2.42 Add to cart
• 

  Article: Highlights in gynaecological cancers

  €2.42 Add to cart